As of November 6, 2026, Park Ha Biological Technology Co., Ltd. is a publicly traded company (Nasdaq: BYAH); its largest reported holder is Corin Global Partners Holdings Limited, with 9.8% on Schedule 13G of August 10, 2026, then Peverel Summit Holdings Limited (9.8%) (Schedule 13G, August 10, 2026).
Is this your company?
About to sign with, pay or invest in Park Ha Biological Technology Co., Ltd.? See the free Snapshot first.
Free to see. No signup.
Is Park Ha Biological Technology Co., Ltd. a real, registered company?
- Park Ha Biological Technology Co., Ltd. files with the SEC under CIK 1986247 (its SEC filings).
- Its shares are listed under the ticker BYAH on Nasdaq (SEC company record).
- Incorporated in F4; business address in Wuxi City, F4, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Park Ha Biological Technology Co., Ltd. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Motovance Holdings Limited (filed 2026-08-13).
Who are Park Ha Biological Technology Co., Ltd.'s owners and officers?
Park Ha Biological Technology Co., Ltd.: business address in Wuxi City, F4; industry Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (Schedule 13G, 2026-08-13).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-08-13 | Motovance Holdings Limited | 9.7% |
| Schedule 13G, 2026-08-10 | Nexera Technology Company Limited | 9.1% |
| Schedule 13G, 2026-08-10 | Corin Global Partners Holdings Limited | 9.8% |
| Schedule 13G, 2026-08-10 | Peverel Summit Holdings Limited | 9.8% |
| Schedule 13G, 2026-08-10 | Rove Trading Co., Limited | 9.8% |
| Schedule 13G, 2026-08-10 | Velociti Group Limited | 9.8% |
| Schedule 13G, 2026-08-10 | Pinnacle International Holding Limited | 7.6% |
| Schedule 13G, 2026-08-10 | Fusen Advertising Design Limited | 9.8% |
Questions about who owns Park Ha Biological Technology Co., Ltd.
Who owns Park Ha Biological Technology Co., Ltd.?
On this page, 8 holders' latest ownership filings report 5% or more of Park Ha Biological Technology Co., Ltd.: Corin Global Partners Holdings Limited (9.8%, Schedule 13G, filed 2026-08-10), Peverel Summit Holdings Limited (9.8%, Schedule 13G, filed 2026-08-10), Rove Trading Co., Limited (9.8%, Schedule 13G, filed 2026-08-10), Velociti Group Limited (9.8%, Schedule 13G, filed 2026-08-10) and Fusen Advertising Design Limited (9.8%, Schedule 13G, filed 2026-08-10); 3 more are listed above.
Who are the largest shareholders of Park Ha Biological Technology Co., Ltd.?
By the share each holder's latest filing reports, the largest holders of Park Ha Biological Technology Co., Ltd. on this page are Corin Global Partners Holdings Limited (9.8%), Peverel Summit Holdings Limited (9.8%) and Rove Trading Co., Limited (9.8%).
When did Corin Global Partners Holdings Limited buy into Park Ha Biological Technology Co., Ltd.?
The filings give report dates, not purchase dates. The earliest filing from Corin Global Partners Holdings Limited on this page is the Schedule 13G, filed 2026-08-10, reporting 9.8%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 8 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Park Ha Biological Technology Co., Ltd.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Park Ha Biological Technology Co., Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Park Ha Biological Technology Co., Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
18 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Park Ha Biological Technology Co., Ltd. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and a director: 381,000 shares (1.5% of shares outstanding), held indirectly through By Xiaoqiu Holding Ltd (Form 3, 2026-04-07).
- Wang Li (Alya), the chief operating officer: 187,500 shares (0.75% of shares outstanding) (Form 3, 2026-08-10).
- , the chief financial officer: 112,500 shares (0.45% of shares outstanding) (Form 4, 2026-08-07).
- , the chief technology officer: 937.5 shares (0.00% of shares outstanding), held indirectly through By Changxin International Limited Partnership (Form 3, 2026-04-07).
Shares outstanding: 25,000,000 as of 2024-10-31, from the company's latest SEC cover page.
How much has Park Ha Biological Technology Co., Ltd. raised?
Latest IPO step: Park Ha Biological Technology Co., Ltd. filed its final IPO prospectus, ticker BYAH (424B4, 2026-01-28).
IPO filings: 424B4, 2026-01-28, F-1/A, 2026-01-23, F-1/A, 2025-12-05, F-1/A, 2025-09-25, F-1, 2025-09-19; ticker BYAH on Nasdaq Capital Market.
Keep reading
More on Park Ha Biological Technology Co., Ltd. and the records around it.
Park Ha Biological Technology Co., Ltd. elsewhere on the record
- 5%+ stake filings Aug 2026
- IPO filing Jan 2026
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/park-ha-biological-technology